OPK Opko Health Inc

Price (delayed)

$3.69

Market cap

$2.51B

P/E Ratio

33.55

Dividend/share

N/A

EPS

$0.11

Enterprise value

$2.69B

Opko Health Inc. is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and ...

Highlights
The company's revenue has surged by 98% YoY and by 8% QoQ
The gross profit has soared by 75% YoY
The net income has soared by 135% year-on-year but it is down by 41% since the previous quarter
Opko Health's EPS has soared by 133% YoY but it has decreased by 42% from the previous quarter
Opko Health's gross margin has decreased by 11% YoY and by 6% from the previous quarter

Key stats

What are the main financial stats of OPK
Market
Shares outstanding
681.16M
Market cap
$2.51B
Enterprise value
$2.69B
Valuations
Price to earnings (P/E)
33.55
Price to book (P/B)
1.42
Price to sales (P/S)
1.25
EV/EBIT
24.93
EV/EBITDA
14.19
EV/Sales
1.41
Earnings
Revenue
$1.91B
EBIT
$107.89M
EBITDA
$189.49M
Free cash flow
$73.47M
Per share
EPS
$0.11
Free cash flow per share
$0.11
Book value per share
$2.6
Revenue per share
$2.95
TBVPS
$2.01
Balance sheet
Total assets
$2.42B
Total liabilities
$679.07M
Debt
$241.87M
Equity
$1.74B
Working capital
$243.05M
Liquidity
Debt to equity
0.14
Current ratio
1.8
Quick ratio
1.09
Net debt/EBITDA
0.93
Margins
EBITDA margin
9.9%
Gross margin
34.7%
Net margin
3.7%
Operating margin
6%
Efficiency
Return on assets
2.9%
Return on equity
4.2%
Return on invested capital
9.4%
Return on capital employed
5.1%
Return on sales
5.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OPK stock price

How has the Opko Health stock price performed over time
Intraday
-0.27%
1 week
-0.81%
1 month
-2.89%
1 year
-13.58%
YTD
-6.58%
QTD
1.1%

Financial performance

How have Opko Health's revenue and profit performed over time
Revenue
$1.91B
Gross profit
$662.4M
Operating income
$115.3M
Net income
$70.91M
Gross margin
34.7%
Net margin
3.7%
The operating income has soared by 170% YoY but it has contracted by 16% from the previous quarter
OPK's operating margin has soared by 135% year-on-year but it is down by 22% since the previous quarter
The net income has soared by 135% year-on-year but it is down by 41% since the previous quarter
The net margin has soared by 118% YoY but it has decreased by 46% QoQ

Growth

What is Opko Health's growth rate over time

Valuation

What is Opko Health stock price valuation
P/E
33.55
P/B
1.42
P/S
1.25
EV/EBIT
24.93
EV/EBITDA
14.19
EV/Sales
1.41
Opko Health's EPS has soared by 133% YoY but it has decreased by 42% from the previous quarter
The P/B is 11% below the last 4 quarters average of 1.6
Opko Health's equity has increased by 10% YoY and by 2.7% QoQ
The company's revenue has surged by 98% YoY and by 8% QoQ
The P/S is 46% below the 5-year quarterly average of 2.3 and 26% below the last 4 quarters average of 1.7

Efficiency

How efficient is Opko Health business performance
OPK's ROIC has soared by 160% year-on-year but it is down by 33% since the previous quarter
The ROE has soared by 134% YoY but it has decreased by 42% QoQ
Opko Health's ROS has soared by 133% YoY but it has decreased by 38% from the previous quarter
The ROA has soared by 133% YoY but it has contracted by 42% from the previous quarter

Dividends

What is OPK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OPK.

Financial health

How did Opko Health financials performed over time
Opko Health's current ratio has increased by 40% YoY and by 22% from the previous quarter
Opko Health's quick ratio has increased by 30% YoY and by 8% from the previous quarter
The debt is 86% lower than the equity
The debt to equity is down by 18% since the previous quarter and by 18% year-on-year
The debt has decreased by 15% QoQ and by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.